Roundtable Video 2. Borderline resectable pancreatic cancer and neoadjuvant therapy

By Alison Shamwana | Started 23rd Nov 2015

IHPBA is delighted to present a series of roundtable discussions on Treatment and Advances in the Surgical Management of Pancreatic Cancer. 

The second in the series, this video captures discussion among the panel on topics including defining the borderline resectable pancreatic patient, the importance of imaging quality, venous versus artery involvement considerations, imaging modality choices, and baseline neoadjuvant therapy protocols.

Other chapters:


Please note there is a discussion forum at the bottom of this page.  If you wish to participate please log in to myHPB.


Participant Background:

Charles Vollmer

Director of Pancreatic Surgery
Co-Chief of Upper Gastrointestinal Oncology at the Abramson Cancer Center
Co-Director of the Penn Pancreatic Cyst Program

Hospital Affiliation: University of Pennsylvania

Expertise: Malignant and benign conditions of the pancreas and biliary system, pancreatitis, pancreatic cystic lesions, pancreatic cancer, and upper gastrointestinal malignancies


Robert C.G. Martin

Sam and Lolita Weakley Professor
Division Director, Division of Surgery

Hospital Affiliation: University of Louisville, Louisville, KY

Expertise: Liver Tumors, Pancreatic, Esophageal, Gastric, Colon, Bile duct, Sarcoma and Melanoma


Professor Michelle de Oliviera

Assistant Professor at University of Zurich

Hospital Affiliation: University of Zurich, Zurich, Switzerland


Professor Nigel Heaton

Professor of Liver Transplant, Hepatobiliary and Pancreatic Surgery

Hospital Affiliation: London Bridge Hospital, London, United Kingdom

Expertise: Living Donor Transplantation, complex hepatobiliary and pancreatic surgery, liver transplantation


This video was produced with grant support from our Corporate Partner, AngioDynamics, Inc. Any opinions, findings, conclusions, or recommendations expressed in this video are those of the individuals appearing in the video and do not necessarily reflect the view of AngioDynamics, Inc.


Comments (0)

Corporate Partners

Ethicon logo
Angiodynamics logo
Sirtex logo
Baxter logo

If you are interested in becoming a Corporate Partner of the IHBPA please contact

Find out more